Growth Capitalist (https://growthcapitalist.com/tag/pipe/page/104/)
Fibrocell Science (FCSC) announced that it has raised $45 million in a Common Stock transaction. The common stock was sold at $0.10 per share, an approximate 57% discount to the market price ($0.23) of FCSC at deal announcement. Barclays Capital, MTS Health Partners and John Carris Investments acted as agents on the transaction. Third Security participated in this offering. The transaction is expected to close by Oct. 11, 2012.
Research Frontiers (REFR) announced that it has raised $5.6 million in a Common Stock transaction with undisclosed investors. The common stock was sold at $4.49 per share, an approximate 0.44% discount to the market price ($4.51) of REFR at deal announcement. A series of 250,000 60-Month Warrants with an exercise price of $6.73 per share (49.22% premium) was issued to the investors in this transaction. Craig-Hallum Capital Group acted as the exclusive agent on the transaction. The transaction is expected to close on Oct.
Document Security Systems (DSS) announced that it has raised $2.75 million in a Common Stock transaction with investors including Lexington Technology Group. The common stock was sold at $3.30 per share, an approximate 24% discount to the market price ($4.32) of DSS at deal announcement. Dawson James Securities acted as the exclusive agent on the transaction with Palladium Capital Advisors acting as the Financial Advisor. The Company also announced they have entered into a merger agreement with Technology Group. The transaction closed on Oct.
Aspen Group (ASPU) announced that it has raised $2.76 million in a Unit (Common Stock and Warrant) transaction with lead investor Sophrosyne Capital. The common stock was sold at $0.35 per share, an approximate 88% discount to the market price ($2.91) of ASPU at deal announcement. A series of 3,938,572 60-Month Warrants with an exercise price of $0.50 per share (82.82% discount) was issued to the investors in this transaction. Laidlaw & Company (UK) Ltd. acted as the exclusive agent on the transaction. Issuer counsel was Nason Yeager Gerson White & Lioce, and investor counsel was K&L Gates.
